報告摘要

Flushing Solution Market Research Report by Type (Saline-Based Solutions, Heparin-Based Solutions, Others), by Application (Gastrointestinal Procedures, Urinary Flushing, Vascular Flushing, Others), by End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers, Research Laboratories & Institutes), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035 Market Overview The global flushing solution market is expected to rise from USD 1,116.05 million in 2024 to USD 2,214.96 million by 2035, reflecting a CAGR of 6.59%. A flushing solution is also a sterile liquid used in healthcare that helps in cleaning, repairing, or unblocking medical devices such as catheters, intravenous lines, and dialysis access points. The device helps in making sure the fluid is flowing properly, lowers the chance of infection, and helps in preventing the formation of clots, with common variants being saline and heparin-based solutions. The surge in diagnostic procedures, particularly colonoscopies and endoscopies, is a key driver of the Global Flushing Solution Market. With millions of gastrointestinal screenings conducted annually and colon cancer cases rising sharply, flushing solutions play a vital role in ensuring accurate results and patient comfort. Their demand is expected to grow steadily as preventive healthcare, lifestyle-related disease management, and advanced diagnostic technologies expand worldwide. Key Company Development In November 2023, Pentaferte Italia strengthened its European presence by collaborating with Medline Europe for the distribution of its sterile pre-filled syringes. The company’s product line, featuring syringes pre-filled with 0.9% saline solution (NaCl), is specifically tailored for flushing vascular access devices, both central and peripheral. This development reflects Pentaferte’s commitment to providing healthcare providers with safe, standardized, and easy-to-use solutions that improve efficiency in clinical practice. Partnering with Medline Europe, a trusted distributor in the medical supply chain, ensures broader market accessibility and reinforces confidence in Pentaferte’s product reliability. By combining innovation with strategic alliances, Pentaferte continues to position itself as a leading name in the sterile syringe segment, driving growth and advancing patient care standards in vascular flushing applications. Major Players Key players in the global flushing solution market are Becton, Dickson and Company, Baxter, B.Braun SE, Amsino International, Inc., Aquabiliti, Medline Industries, LP, McKesson Corporation, SPM Medicare Pvt. Ltd., Polymedicure, Medefil, Inc., Tianhe Pharmaceutical Co., Ltd, and Pentaferte. Report Attribute Details Market Size 2024 USD 1,116.05 Million Market Size 2035 USD 2,214.96 Million CAGR (2025-2035) 6.59% Base Year 2024 Market Forecast Period 2025-2035 Historical Data 2019-2024 Market Segmentations By Type: Saline-Based Solutions - 6.50%, Heparin-Based Solutions - 7.30%. By Application: Gastrointestinal Procedures - 7.14%, Urinary Flushing - 6.45%. By End User: Hospitals and Specialty Clinics - 6.17%, Ambulatory Surgical Centers - 8.02%. Regional Insights North America is a mature market for flushing solutions, and the development of the well-established healthcare infrastructure and the high patient awareness of infection control are the main factors that drive. The United States dominates the flushing solution market with USD 385.92 million, while Canada contributes USD 51.90 million, underscoring the U.S. as the primary growth hub of the region. The emphasis on patient safety by the regulators and the prevention of catheter-associated complications is still a major factor for market expansion in the region. The healthcare regulations in Europe have a significant influence on the flushing solution market, whose demand is also supported by hospitals' high hygiene standard requirements. Germany leads the European flushing solution market with USD 89.27 million, followed by the UK at USD 71.95 million and France at USD 64.06 million, reflecting the dominance of Western Europe in regional demand. Asia-Pacific is witnessing the fastest growth in the flushing solution market, driven by rising healthcare expenditures and expanding access to clinical care in developing economies. China leads with USD 73.70 million, closely followed by India at USD 56.36 million, highlighting their pivotal role in driving regional demand for flushing solutions. Increasing medical tourism and higher awareness of patient safety protocols also create opportunities for international manufacturers. The Rest of the World region, including Latin America, the Middle East, and Africa, is gradually adopting flushing solutions as healthcare infrastructure is being built. In Africa, international collaborations and government healthcare initiatives are creating long-term potential.

目錄 Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ........... 16 2 MARKET INTRODUCTION ........ 18 2.1 DEFINITION ............ 18 2.2 SCOPE OF THE STUDY ............ 18 2.3 RESEARCH OBJECTIVE .......... 18 2.4 MARKET STRUCTURE ............ 19 3 RESEARCH METHODOLOGY ............ 20 3.1 OVERVIEW .... 20 3.2 DATA FLOW ............ 22 3.2.1 DATA MINING PROCESS ......... 22 3.3 PURCHASED DATABASE: ....... 23 3.4 SECONDARY SOURCES: .......... 24 3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 25 3.5 PRIMARY RESEARCH: ... 26 3.5.1 PRIMARY RESEARCH DATA FLOW: ... 27 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ... 28 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ........ 28 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........... 29 3.6.1 REVENUE ANALYSIS APPROACH ....... 29 3.7 DATA FORECASTING..... 30 3.7.1 DATA FORECASTING TYPE ...... 30 3.8 DATA MODELING ............ 31 3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 31 3.8.2 DATA MODELING: ......... 32 3.9 TEAMS AND ANALYST CONTRIBUTION ....... 34 4 MARKET DYNAMICS ...... 36 4.1 INTRODUCTION ..... 36 4.2 DRIVERS ......... 37 4.2.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES LIKE COLONOSCOPIES AND ENDOSCOPIES ........... 37 4.2.2 GROWING PREVALENCE OF KIDNEY STONES ......... 37 4.3 RESTRAINTS .......... 38 4.3.1 STRINGENT REGULATORY REQUIREMENTS............ 38 4.3.2 LACK OF AWARENESS IN DEVELOPING REGIONS ... 38 4.4 OPPORTUNITY ....... 40 4.4.1 RISING AGING POPULATION ... 40 4.4.2 INCREASED ADOPTION OF MINIMALLY INVASIVE PROCEDURES........... 40 5 MARKET FACTOR ANALYSIS ............ 41 5.1 PORTER'S FIVE FORCES MODEL ... 41 5.1.1 THREAT OF NEW ENTRANTS ... 41 5.1.2 BARGAINING POWER OF SUPPLIERS ........... 42 5.1.3 THREAT OF SUBSTITUTES ...... 42 5.1.4 BARGAINING POWER OF BUYERS ...... 42 5.1.5 INTENSITY OF RIVALRY .......... 42 5.2 IMPACT OF COVID-19 ON THE GLOBAL FLUSHING SOLUTION MARKET ...... 42 6 GLOBAL FLUSHING SOLUTION MARKET, BY TYPE ...... 45 6.1 OVERVIEW .... 45 6.2 SALINE-BASED SOLUTIONS ........... 46 6.3 HEPARIN-BASED SOLUTIONS ........ 47 6.4 OTHERS .......... 47 7 GLOBAL FLUSHING SOLUTION MARKET, BY APPLICATION ............ 48 7.1 OVERVIEW .... 48 7.2 GASTROINTESTINAL PROCEDURES ...... 49 7.3 URINARY FLUSHING ..... 50 7.4 VASCULAR FLUSHING ............ 50 7.5 OTHERS .......... 51 8 GLOBAL FLUSHING SOLUTION MARKET, BY END USER ....... 52 8.1 OVERVIEW .... 52 8.2 HOSPITALS AND SPECIALTY CLINICS ............ 54 8.3 AMBULATORY SURGICAL CENTERS (ASCS) .......... 54 8.4 RESEARCH LABORATORIES & INSTITUTES ........... 55 9 GLOBAL FLUSHING SOLUTION MARKET, BY REGION ........... 56 9.1 OVERVIEW .... 56 9.2 NORTH AMERICA ........... 57 9.2.1 US............ 60 9.2.2 CANADA ............ 61 9.3 EUROPE .......... 62 9.3.1 GERMANY .......... 65 9.3.2 FRANCE ... 66 9.3.3 UK ........... 67 9.3.4 SPAIN ...... 68 9.3.5 ITALY ....... 69 9.3.6 REST OF EUROPE .......... 70 9.4 ASIA-PACIFIC ......... 71 9.4.1 CHINA ...... 73 9.4.2 INDIA ....... 75 9.4.3 JAPAN ..... 76 9.4.4 AUSTRALIA, ....... 77 9.4.5 SOUTH KOREA .... 78 9.4.6 REST OF ASIA-PACIFIC ........... 79 9.5 REST OF THE WORLD .... 81 9.5.1 MIDDLE EAST AND AFRICA ..... 83 9.5.2 SOUTH AMERICA .......... 84 10 COMPETITIVE LANDSCAPE .... 87 10.1 INTRODUCTION ..... 87 10.2 MARKET SHARE ANALYSIS, 2024 ......... 87 10.3 COMPETITOR DASHBOARD... 88 10.4 PUBLIC PLAYERS STOCK SUMMARY ... 89 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ........ 89 10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ............ 90 10.1.1 PARTNERSHIP .... 90 11 COMPANY PROFILES .... 91 11.1 MCKESSON CORPORATION ... 91 11.1.1 COMPANY OVERVIEW ... 91 11.1.2 FINANCIAL OVERVIEW ............ 92 11.1.3 PRODUCTS OFFERED .... 92 11.1.4 KEY DEVELOPMENTS .... 92 11.1.5 SWOT ANALYSIS .......... 93 11.1.6 KEY STRATEGIES .......... 93 11.2 SPM MEDICARE PVT. LTD. .... 94 11.2.1 COMPANY OVERVIEW ... 94 11.2.2 FINANCIAL OVERVIEW ............ 95 11.2.3 PRODUCTS OFFERED .... 95 11.2.4 KEY DEVELOPMENTS .... 95 11.2.5 SWOT ANALYSIS .......... 95 11.2.6 KEY STRATEGIES .......... 96 11.3 POLYMEDICURE .... 97 11.3.1 COMPANY OVERVIEW ... 97 11.3.2 FINANCIAL OVERVIEW ............ 98 11.3.3 PRODUCTS OFFERED .... 98 11.3.4 KEY DEVELOPMENTS .... 99 11.3.5 KEY STRATEGIES .......... 99 11.4 MEDEFIL, INC. ........ 100 11.4.1 COMPANY OVERVIEW ... 100 11.4.2 FINANCIAL OVERVIEW ............ 100 11.4.3 PRODUCTS OFFERED .... 101 11.4.4 KEY DEVELOPMENTS .... 101 11.4.5 KEY STRATEGIES .......... 101 11.5 TIANHE PHARMACEUTICAL CO., LTD. ........... 102 11.5.1 COMPANY OVERVIEW ... 102 11.5.2 FINANCIAL OVERVIEW ............ 102 11.5.3 PRODUCTS OFFERED .... 102 11.5.4 KEY DEVELOPMENTS .... 102 11.5.5 KEY STRATEGIES .......... 103 11.6 PENTAFERTE ......... 104 11.6.1 COMPANY OVERVIEW ... 104 11.6.2 FINANCIAL OVERVIEW ............ 104 11.6.3 PRODUCTS OFFERED .... 104 11.6.4 KEY DEVELOPMENTS .... 105 11.6.5 KEY STRATEGIES .......... 105 11.7 BECTON, DICKINSON AND COMPANY ............ 106 11.7.1 COMPANY OVERVIEW ... 106 11.7.2 FINANCIAL OVERVIEW ............ 107 11.7.3 PRODUCTS OFFERED .... 107 11.7.4 KEY DEVELOPMENTS .... 107 11.7.5 SWOT ANALYSIS .......... 108 11.7.6 KEY STRATEGIES .......... 108 11.8 BAXTER ......... 109 11.8.1 COMPANY OVERVIEW ... 109 11.8.2 FINANCIAL OVERVIEW ............ 110 11.8.3 PRODUCTS OFFERED .... 111 11.8.4 KEY DEVELOPMENTS .... 111 11.8.5 SWOT ANALYSIS .......... 111 11.8.6 KEY STRATEGIES .......... 112 11.9 B. BRAUN SE ........... 113 11.9.1 COMPANY OVERVIEW ... 113 11.9.2 FINANCIAL OVERVIEW ............ 114 11.9.3 PRODUCTS OFFERED .... 115 11.9.4 KEY DEVELOPMENTS .... 115 11.9.5 SWOT ANALYSIS .......... 116 11.9.6 KEY STRATEGIES .......... 116 11.10 AMSINO INTERNATIONAL, INC .... 117 11.10.1 COMPANY OVERVIEW ... 117 11.10.2 FINANCIAL OVERVIEW ............ 118 11.10.3 PRODUCTS OFFERED .... 118 11.10.4 KEY DEVELOPMENTS .... 118 11.10.5 KEY STRATEGIES .......... 118 11.11 AQUABILITI ............ 119 11.11.1 COMPANY OVERVIEW ... 119 11.11.2 FINANCIAL OVERVIEW ............ 119 11.11.3 PRODUCT OFFERED ...... 119 11.11.4 KEY DEVELOPMENTS .... 120 11.11.5 KEY STRATEGIES .......... 120 11.12 MEDLINE INDUSTRIES, LP .... 121 11.12.1 COMPANY OVERVIEW ... 121 11.12.2 FINANCIAL OVERVIEW ............ 121 11.12.3 PRODUCT OFFERED ...... 121 11.12.4 KEY DEVELOPMENTS .... 121 11.12.5 KEY STRATEGIES .......... 121 12 DATA CITATIONS ........... 123

圖表清單 List of Tables & Figures

LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 32 TABLE 2 GLOBAL FLUSHING SOLUTION MARKET, BY TYPE, 2019–2035 (USD BILLION) 46 TABLE 3 GLOBAL FLUSHING SOLUTION MARKET, FOR SALINE-BASED SOLUTIONS, BY REGION, 2019–2035 (USD BILLION) 46 TABLE 4 GLOBAL FLUSHING SOLUTION MARKET, FOR HEPARIN-BASED SOLUTIONS, BY REGION, 2019–2035 (USD BILLION) 47 TABLE 5 GLOBAL FLUSHING SOLUTION MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD BILLION) 47 TABLE 6 GLOBAL FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD BILLION) 49 TABLE 7 GLOBAL FLUSHING SOLUTION MARKET, FOR GASTROINTESTINAL PROCEDURES, BY REGION, 2019–2035 (USD BILLION) 49 TABLE 8 GLOBAL FLUSHING SOLUTION MARKET, FOR URINARY FLUSHING, BY REGION, 2019–2035 (USD BILLION) 50 TABLE 9 GLOBAL FLUSHING SOLUTION MARKET, FOR VASCULAR FLUSHING, BY REGION, 2019–2035 (USD BILLION) 50 TABLE 10 GLOBAL FLUSHING SOLUTION MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD BILLION) 51 TABLE 11 GLOBAL FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD BILLION) 53 TABLE 12 GLOBAL FLUSHING SOLUTION MARKET, FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019–2035 (USD BILLION) 54 TABLE 13 GLOBAL FLUSHING SOLUTION MARKET, FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2019–2035 (USD BILLION) 54 TABLE 14 GLOBAL FLUSHING SOLUTION MARKET, FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019–2035 (USD BILLION) 55 TABLE 15 GLOBAL FLUSHING SOLUTION MARKET, BY REGION, 2019-2035 (USD MILLION) 56 TABLE 16 NORTH AMERICA FLUSHING SOLUTIONS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 58 TABLE 17 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 59 TABLE 18 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 59 TABLE 19 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 60 TABLE 20 US: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 60 TABLE 21 US: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60 TABLE 22 US: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) TABLE 23 CANADA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) TABLE 24 CANADA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 61 TABLE 25 CANADA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 62 TABLE 26 EUROPE: FLUSHING SOLUTIONS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 63 TABLE 27 EUROPE: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) TABLE 28 EUROPE: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 64 TABLE 29 EUROPE: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 64 TABLE 30 GERMANY: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 65 TABLE 31 GERMANY: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 65 TABLE 32 GERMANY: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 65 TABLE 33 FRANCE: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) TABLE 34 FRANCE: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 66 TABLE 35 FRANCE: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 66 TABLE 36 UK: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 67 TABLE 37 UK: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 67 TABLE 38 UK: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) TABLE 39 SPAIN: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 68 TABLE 40 SPAIN: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 68 TABLE 41 SPAIN: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 68 TABLE 42 ITALY: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 69 TABLE 43 ITALY: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 69 TABLE 44 ITALY: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 69 TABLE 45 REST OF EUROPE: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 70 TABLE 46 REST OF EUROPE: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 70 TABLE 47 REST OF EUROPE: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 70 TABLE 48 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 72 TABLE 49 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 72 TABLE 50 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 73 TABLE 51 ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 73 TABLE 52 CHINA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 73 TABLE 53 CHINA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 74 TABLE 54 CHINA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 74 TABLE 55 INDIA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 75 TABLE 56 INDIA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 75 TABLE 57 INDIA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 75 TABLE 58 JAPAN: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 76 TABLE 59 JAPAN: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 76 TABLE 60 JAPAN: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 76 TABLE 61 AUSTRALIA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 77 TABLE 62 AUSTRALIA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 77 TABLE 63 AUSTRALIA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 78 TABLE 64 SOUTH KOREA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 78 TABLE 65 SOUTH KOREA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 78 TABLE 66 SOUTH KOREA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 79 TABLE 67 REST OF ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 79 TABLE 68 REST OF ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 80 TABLE 69 REST OF ASIA-PACIFIC: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 80 TABLE 70 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 82 TABLE 71 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 82 TABLE 72 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 83 TABLE 73 REST OF THE WORLD: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 83 TABLE 74 MIDDLE EAST AND AFRICA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 83 TABLE 75 MIDDLE EAST AND AFRICA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 84 TABLE 76 MIDDLE EAST AND AFRICA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 84 TABLE 77 SOUTH AMERICA: FLUSHING SOLUTION MARKET, BY TYPE 2019–2035 (USD MILLION) 84 TABLE 78 SOUTH AMERICA: FLUSHING SOLUTION MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 85 TABLE 79 SOUTH AMERICA: FLUSHING SOLUTION MARKET, BY END USER, 2019–2035 (USD MILLION) 85 TABLE 80 PARTNERSHIP 90 TABLE 81 MCKESSON CORPORATION: PRODUCTS OFFERED 92 TABLE 82 SPM MEDICARE PVT. LTD.: PRODUCTS OFFERED 95 TABLE 83 POLYMEDICURE: PRODUCTS OFFERED 98 TABLE 84 MEDEFIL, INC.: PRODUCTS OFFERED 101 TABLE 85 TIANHE PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED 102 TABLE 86 PENTAFERTE: PRODUCTS OFFERED TABLE 87 PENTAFERTE: KEY DEVELOPMENTS TABLE 88 BECTON, DICKINSON AND COMPANY: PRODUCT OFFERED TABLE 89 BAXTER: PRODUCT OFFERED TABLE 90 B. BRAUN SE: PRODUCTS OFFERED TABLE 91 AMSINO INTERNATIONAL, INC: PRODUCTS OFFERED TABLE 92 AQUABILITI: PRODUCTS OFFERED TABLE 93 MEDLINE INDUSTRIES, LP: PRODUCTS OFFERED LIST OF FIGURES FIGURE 1 GLOBAL FLUSHING SOLUTION MARKET: STRUCTURE 19 FIGURE 2 GLOBAL FLUSHING SOLUTION MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2035) 36 FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035) 38 FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035) 39 FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL FLUSHING SOLUTION MARKET FIGURE 6 GLOBAL FLUSHING SOLUTION MARKET TYPE SEGMENT, 2024 & 2035 (USD MILLION) 45 FIGURE 7 GLOBAL FLUSHING SOLUTION MARKET, BY TYPE, 2024 & 2035 (USD BILLION) FIGURE 8 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY TYPE, 2024 46 FIGURE 9 GLOBAL FLUSHING SOLUTION MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 48 FIGURE 10 GLOBAL FLUSHING SOLUTION MARKET, BY APPLICATION, 2024 & 2035 (USD BILLION) 48 FIGURE 11 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY APPLICATION, 2024 FIGURE 12 GLOBAL FLUSHING SOLUTION MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 52 FIGURE 13 GLOBAL FLUSHING SOLUTION MARKET, BY END USER, 2024 & 2035 (USD BILLION) 52 FIGURE 14 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY END USER, 2024 53 FIGURE 15 GLOBAL FLUSHING SOLUTION MARKET, BY REGION, 2024 & 2035 (USD MILLION) 56 FIGURE 16 GLOBAL FLUSHING SOLUTION MARKET SHARE (%), BY REGION, 2024 57 FIGURE 17 NORTH AMERICA MARKET ANALYSIS: FLUSHING SOLUTION MARKET, 2019-2035 (USD MILLION) 57 FIGURE 18 NORTH AMERICA: FLUSHING SOLUTION MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 58 FIGURE 19 NORTH AMERICA: FLUSHING SOLUTION MARKET SHARE (%), BY COUNTRY, 2024 59 FIGURE 20 EUROPE MARKET ANALYSIS: FLUSHING SOLUTION MARKET, 2019-2035 (USD MILLION) 62 FIGURE 21 EUROPE: FLUSHING SOLUTIONS MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 63 FIGURE 22 EUROPE: FLUSHING SOLUTIONS MARKET SHARE, BY COUNTRY, 2024 (%) FIGURE 23 ASIA-PACIFIC: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 71 FIGURE 24 ASIA-PACIFIC: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 (%) 72 FIGURE 25 REST OF THE WORLD: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 81 FIGURE 26 REST OF THE WORLD: FLUSHING SOLUTION MARKET SHARE, BY COUNTRY, 2024 (%) 82 FIGURE 27 GLOBAL FLUSHING SOLUTION MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 87 FIGURE 28 COMPETITOR DASHBOARD: GLOBAL FLUSHING SOLUTION MARKET 88 FIGURE 29 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 92 FIGURE 30 MCKESSON CORPORATION: SWOT ANALYSIS 93 FIGURE 31 SPM MEDICARE PVT. LTD.: SWOT ANALYSIS 95 FIGURE 32 POLYMEDICURE: FINANCIAL OVERVIEW SNAPSHOT 98 FIGURE 33 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT FIGURE 34 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS 108 FIGURE 35 BAXTER: FINANCIAL OVERVIEW SNAPSHOT 110 FIGURE 36 BAXTER: SWOT ANALYSIS 111 FIGURE 37 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT 114 FIGURE 38 B. BRAUN SE: SWOT ANALYSIS 116

Single User Price	$4,950 USD
Multi User Licence (up to 10 users)	$5,950 USD
Enterprisewide Price (Global Site License)	$7,250 USD

授權報價

報告摘要

提及公司

同分類最新報告（醫療與生命科學）